{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"LTE60","restrictiveAgreement":true},"limitationsAndCaveats":{"description":"A business decision was made to stop enrollment and the study was discontinued on 17 November 2020. Consistent with Food and Drug Administration and International Council for Harmonisation guidance on the content for abbreviated and synoptic CSRs, only safety data are analyzed and reported."},"pointOfContact":{"email":"holly.beever@oncology.sumitomo-pharma.com","organization":"Sumitomo Oncology","phone":"210-365-9014","title":"Holly Beever"}}